| Literature DB >> 32294696 |
Livia Carla Vinhal Frutuoso1, André Ricardo Ribas Freitas2,3, Luciano Pamplona de Góes Cavalcanti4, Elisabeth Carmen Duarte5.
Abstract
INTRODUCTION: In 2014, the first cases of autochthonous chikungunya (CHIK) were recorded in Brazil. Lethality associated with this disease is underestimated. Thus, this study aimed to analyze the causes of death among individuals with CHIK in Brazil.Entities:
Mesh:
Year: 2020 PMID: 32294696 PMCID: PMC7182291 DOI: 10.1590/0037-8682-0580-2019
Source DB: PubMed Journal: Rev Soc Bras Med Trop ISSN: 0037-8682 Impact factor: 1.581
FIGURE 1:Flow selection of chikungunya patients who died within 6 months in Brazil in 2016 and 2017 using the SINAN and SIM information system linkage process. *Except for individuals with mention of chikungunya in the DC (n=14). **Duplicates generated using the database linkage process when one DC was paired with two cases in SINAN. ***Patients who died with DCs mentioning chikungunya as an underlying or associated cause but was not paired with any cases in SINAN. ****In two of these cases, chikungunya was not an underlying cause. *****In sixteen of these cases chikungunya was mentioning (n=8, underlying cause and n=8, associated cause).
FIGURE 2:Sources of information about deaths from chikungunya after the SIM and Sinan information system linkage in 2016 and 2017 in Brazil. *All deaths recorded in SIM were included (with or without mention of chikungunya in the DC), which were paired with chikungunya cases recorded in Sinan, plus deaths recorded in SIM with DCs mentioning chikungunya but without pairing with chikungunya cases in Sinan.
Distribution of underlying causes recorded in SIM for death certificates mentioning chikungunya after SIM/Sinan pairing according to the case confirmation criterion* recorded in Sinan, 2016 and 2017 in Brazil.
| Underlying cause group | Confirmed case | Probable case | Total | |||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Arthropod-borne and viral hemorrhagic fevers (A90-A99) | 271 | 40.4 | 360 | 14.6 | 631 | 20.1 |
| Chikungunya (A920) | 253 | 27.4 | 298 | 10.8 | 551 | 17.6 |
| Malignant neoplasms (C00-C97) | 27 | 4.0 | 220 | 8.9 | 247 | 7.9 |
| Influenza and pneumonia (J09-J18) | 38 | 5.7 | 177 | 7.2 | 215 | 6.9 |
| Ischemic heart diseases (I20-I25) | 27 | 4.0 | 164 | 6.7 | 191 | 6.1 |
| Diabetes mellitus (E10-E140) | 26 | 3.9 | 154 | 6.3 | 180 | 5.7 |
| Cerebrovascular diseases (I60-I69) | 30 | 4.5 | 143 | 5.8 | 173 | 5.5 |
| Other types of heart disease (I30-I52) | 17 | 2.5 | 120 | 4.9 | 137 | 4.4 |
| Ill-defined conditions (R00-R99) | 18 | 2.7 | 115 | 4.7 | 133 | 4.2 |
| Other bacterial diseases (A30-A49) | 13 | 1.9 | 81 | 3.3 | 94 | 3.0 |
| Other respiratory system diseases (J60-J99) | 15 | 2.2 | 79 | 3.2 | 94 | 3.0 |
| Diseases of the blood and certain immune disorders (D50-D89) | 21 | 3.1 | 70 | 2.8 | 91 | 2.9 |
| Chronic diseases of the lower respiratory tract (J40-J47) | 9 | 1.3 | 47 | 1.9 | 56 | 1.8 |
| Diseases of the liver (K70-K77) | 7 | 1.0 | 48 | 1.9 | 55 | 1.8 |
| Kidney failure (N17-N19) | 8 | 1.2 | 47 | 1.9 | 55 | 1.8 |
| Other urinary system diseases (N30-N39) | 9 | 1.3 | 45 | 1.8 | 54 | 1.7 |
| Hypertensive diseases (I10-I15) | 8 | 1.2 | 42 | 1.7 | 50 | 1.6 |
| Systemic atrophy affecting the CNS (G10-G59 and G70-G99) | 13 | 1.9 | 34 | 1.4 | 47 | 1.5 |
| HIV disease (B20-B24) | 4 | 0.6 | 41 | 1.7 | 45 | 1.4 |
| Viral infection of the central nervous system (A80-A89) | 12 | 1.8 | 22 | 0.9 | 34 | 1.1 |
| Certain conditions that occurred in the perinatal period (P00-P96) | 5 | 0.7 | 5 | 0.2 | 10 | 0.3 |
| Other causes | 93 | 13.9 | 450 | 18.3 | 543 | 17.3 |
|
|
|
|
|
|
|
|
Source: Sinan/SIM. *Confirmed case: laboratory-confirmed cases (presence of a specific laboratory test with positive results - real-time polymerase chain reaction, virus isolation, and IgM and IgG serology). Probable case: cases confirmed clinical epidemiological criterion or with the final classification and/or confirmation criterion unknown and blank or deaths identified exclusively in SIM (n=328).
Phase* of the disease during which death occurred, with mention of chikungunya in the death certificate (DC), and final case classification (confirmed or probable) in 2016 and 2017 in Brazil.
| Chikungunya mentioned in the DC | Phase | Confirmed case | Probable case | Total | |||
|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | ||
| Chikungunya as an underlying cause | Acute | 140 | 57 | 72 | 75 | 212 | 62 |
| Post-acute | 88 | 36 | 19 | 20 | 107 | 31 | |
| Chronic | 17 | 7 | 5 | 5 | 22 | 6 | |
|
|
|
|
|
|
|
| |
| Chikungunya as the associated cause | Acute | 17 | 43 | 18 | 49 | 35 | 45 |
| Post-acute | 18 | 45 | 10 | 27 | 28 | 36 | |
| Chronic | 5 | 13 | 9 | 24 | 14 | 18 | |
|
|
|
|
|
|
|
| |
| No mention of chikungunya | Acute | 151 | 41 | 795 | 42 | 946 | 41 |
| Post-acute | 141 | 38 | 653 | 34 | 794 | 35 | |
| Chronic | 79 | 21 | 466 | 24 | 545 | 24 | |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
*Cases with inconsistent or missing symptom onset date were excluded from the analysis (n=432).
Corrected indicators according to the region of residence and characteristics of patients who died with death certificates mentioning chikungunya in Sinan and/or SIM in 2016 and 2017 in Brazil.
| Characteristics | No. of | Incidence | No. of deaths | No. of | Lethality rate | Corrected | Lethality | Relative |
|---|---|---|---|---|---|---|---|---|
| cases* | coefficient | in Sinan | corrected deaths | in Sinan | lethality rate | ratio** | risk*** | |
|
| ||||||||
| N | 39,466 | 220.0 | 9 | 118 | 0.2 | 3.0 | 13.1 | 1.6 |
| NE | 437,327 | 763.8 | 414 | 2,703 | 0.9 | 6.2 | 6.5 | 3.3 |
| SE | 60,774 | 69.9 | 37 | 273 | 0.6 | 4.5 | 7.4 | 2.4 |
| S | 5,876 | 19.8 | 0 | 11 | 0.0 | 1.9 | ... | 1.0 |
| MW | 8,872 | 55.9 | 4 | 30 | 0.5 | 3.4 | 7.5 | 1.8 |
| Unknown/blank | 36 | |||||||
|
| ||||||||
| Male | 208,249 | 203.2 | 237 | 1,541 | 1.1 | 7.4 | 6.5 | 1.6 |
| Female | 343,671 | 326.7 | 227 | 1,594 | 0.7 | 4.6 | 7.0 | 1.0 |
| Unknown/blank | 431 | |||||||
|
| ||||||||
| <1 | 7,484 | 274.2 | 19 | 64 | 2.5 | 8.6 | 3.4 | 5.6 |
| 1-14 | 64,475 | 149.2 | 22 | 106 | 0.3 | 1.6 | 4.8 | 1.1 |
| 15-44 | 281,567 | 299.6 | 54 | 428 | 0.2 | 1.5 | 7.9 | 1.0 |
| 45-64 | 139,571 | 379.7 | 78 | 673 | 0.6 | 4.8 | 8.6 | 3.2 |
| 65-79 | 47,490 | 425.2 | 137 | 982 | 2.9 | 20.7 | 7.2 | 13.6 |
| ≥80 | 11,695 | 400.9 | 154 | 882 | 13.3 | 75.4 | 5.7 | 49.6 |
| Unknown/blank | 69 | |||||||
|
| ||||||||
| None | 36,782 | 175.3 | 52 | 618 | 1.4 | 16.8 | 11.8 | 3.4 |
| 1-3 | 23,836 | 71.6 | 107 | 803 | 4.5 | 33.7 | 7.5 | 6.9 |
| 4-7 | 39,229 | 117.9 | 73 | 486 | 1.9 | 12.4 | 6.7 | 2.5 |
| 8-11 | 83,725 | 110.8 | 90 | 408 | 1.1 | 4.9 | 4.5 | 1.0 |
| ≥12 | 19,471 | 58.8 | 41 | 155 | 2.1 | 8.0 | 3.8 | 1.6 |
| Unknown | 349,308 | 60 | 495 | |||||
|
| ||||||||
| White | 65,131 | 71.5 | 192 | 949 | 3.0 | 14.6 | 4.9 | 16.0 |
| Black | 16,475 | 113.5 | 17 | 183 | 1.0 | 11.1 | 10.8 | 12.2 |
| Yellow | 4,402 | 211.2 | 0 | 4 | 0.0 | 0.9 | ... | 1.0 |
| Brown | 301,053 | 365.9 | 242 | 1871 | 0.8 | 6.2 | 7.7 | 6.8 |
| Indigenous | 1,923 | 235.1 | 1 | 7 | 0.5 | 3.6 | 7.0 | 4.0 |
| Unknown | 163,367 | 12 | 121 | |||||
|
| 552,351 | 266 | 464 | 3,135 | 0.8 | 5.7 | 6.8 |
Source: Sinan/SIM and Brazilian Institute of Geography and Statistics - IBGE. *Sinan cases plus 328 cases recovered from SIM. **Corrected Sinan/SIM lethality ratio. ***Corrected lethality rate.